As of 30 Sep 2025, 1 institutional investors reported holding 81,988 shares of Arrowhead Pharma Inc - COM (ARWR).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 81,988 | $2,827,766 | -$418,157 | $34.49 | 1 |
| 2025 Q2 | 94,112 | $1,486,970 | $15.80 | 1 | |
| 2025 Q1 | 94,112 | $1,198,987 | +$1,198,987 | $12.74 | 1 |
| 2021 Q4 | 0 | $0 | -$393,000 | $34.49 | 0 |
| 2021 Q3 | 6,000 | $393,000 | +$196,500 | $65.50 | 1 |
| 2021 Q2 | 3,000 | $248,000 | +$248,000 | $82.67 | 1 |
| 2020 Q2 | 0 | $0 | -$13,299,000 | $34.49 | 0 |
| 2020 Q1 | 462 | $13,299,000 | -$1,722,071 | $28785.71 | 1 |
| 2019 Q4 | 4,513 | $317,000 | +$254,000 | $93.15 | 2 |
| 2016 Q3 | 0 | $0 | -$3,000 | $34.49 | 0 |
| 2016 Q2 | 470 | $3,000 | -$87,304,000 | $6.38 | 1 |
| 2016 Q1 | 18,309,683 | $88,225,000 | -$23,838,795 | $4.82 | 72 |
| 2015 Q4 | 22,165,576 | $136,300,581 | -$20,832,888 | $6.15 | 95 |
| 2015 Q3 | 25,672,060 | $147,843,533 | -$9,695,531 | $5.76 | 100 |
| 2015 Q2 | 27,123,730 | $193,925,936 | -$28,553,407 | $7.15 | 93 |
| 2015 Q1 | 31,355,458 | $212,081,774 | -$28,991,059 | $6.77 | 87 |
| 2014 Q4 | 35,271,434 | $259,729,696 | -$131,887,765 | $7.38 | 98 |
| 2014 Q3 | 36,741,372 | $541,921,730 | -$33,054,305 | $14.77 | 109 |
| 2014 Q2 | 39,103,718 | $558,823,217 | -$8,990,936 | $14.31 | 111 |
| 2014 Q1 | 38,847,658 | $637,024,070 | +$251,556,697 | $16.42 | 98 |